S. C. Kachlany,1,3
M. Tomich,1
D. H. Fine,3 and
D. H. Figurski1*
Department of Microbiology, College of Physicians and Surgeons Columbia University, New York, New York 10032,1 Molecular Laboratories, American Museum of Natural History, New York, NY 10024,2 Department of Oral Biology, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 071033
Received 7 April 2006/ Accepted 13 June 2006
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The tad locus is arranged as an operon that extends from flp-1 to tadG (Fig. 1) and is expressed as a single transcriptional unit from flp-1 through at least tadD (11). The product of the flp-1 prepilin gene is the major component of purified pili (17, 19). Flp1 is a type IVb prepillin protein (20) that is posttranslationally modified, most likely by glycosylation, and processed into a mature form prior to pilus assembly (16). The tadA gene product is homologous to secretion NTPases of type IV secretion, such as VirB11, and has been shown to have ATPase activity (1, 27). Two outer membrane components encoded by the tad locus, RcpA and RcpB, were identified in rough strains of A. actinomycetemcomitans (12). RcpA is a member of the GspD/OutD/PulD secretin family of proteins (12, 19) and is predicted to form the outer membrane channel for the secretion of pili (19). Many of the proteins encoded by the tad locus have no assigned functions and have no obvious homology to other known members of prokaryotic secretion systems.
|
In previous studies, random mutagenesis and genetic complementation were utilized to demonstrate the requirement of 11 tad locus genes (flp-1, rcpA, rcpC, and tadZABCDEFG) for adherence (18, 20, 28). Mutations in any of these 11 tad genes resulted in the loss of all adherence-related phenotypes of biofilm formation, autoaggregation, rough colony morphology, and Flp pili production. We were unable to identify transposon insertions in flp-2, tadV, and rcpB. A recent study by Wang and Chen (40), in which insertional mutations were targeted to every gene in the tad locus of A. actinomycetemcomitans (40), also did not show a role for flp-2, tadV, and rcpB in tenacious biofilm formation or Flp pilus production. The authors did not genetically complement the mutations in flp-2, tadV, and rcpB; therefore, the involvement of all three genes remains unclear.
Sequence similarities suggested potential roles for flp-2 and tadV. The predicted product of flp-2 is similar to type IV pilins and demonstrates 50% amino acid identity to Flp1, the major pilin subunit (17, 20). The predicted product of tadV is similar to prepillin peptidases found in type II secretion systems (28), and its homolog in C. crescentus, cpaA, has been shown to be required for pilus formation (35). Here we show that tadV is also essential for adherence and Flp fibril production. Our original mutagenesis scheme failed to detect it (18, 28). The rcpB gene is unique to the tad loci and found only in close relatives of A. actinomycetemcomitans. The rcpB gene has no clear predicted function.
Here we use a targeted mutagenesis strategy (M. Bhattacharjee and D. H. Figurski, unpublished data), coupled with genetic complementation analysis, to test whether flp-2, tadV, and rcpB are required for biofilm formation. We show that tadV is required for adherence, whereas mutations in flp-2 do not disrupt tenacious biofilm formation, autoaggregation, rough colony morphology, or Flp pilus formation. We also present expression and phylogenetic studies that strongly suggest that flp-2 is no longer expressed in A. actinomycetemcomitans. We were unable to disrupt rcpB in wild-type adherent A. actinomycetemcomitans, but we were able to mutagenize rcpB in a tad mutant strain of A. actinomycetemcomitans that is spontaneously nonadherent, makes no Flp fibrils, does not autoaggregate, and does not make rough colonies. These findings suggest that rcpB is essential to A. actinomycetemcomitans in the context of a functional Tad secretion system. The phenotypes displayed by both flp-2 and rcpB mutants explain why random transposon insertions were not found in flp-2 and rcpB in our early mutagenesis studies.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
DNA procedures. All plasmid preparations were done using Miniprep Spin Kits (QIAGEN), and DNA manipulations with restriction enzymes and T4 DNA ligase were done according to the manufacturer's recommendations (New England Biolabs). PCR amplification was done with either high-fidelity Triplemaster Taq polymerase or Taq polymerase (Eppendorf) for 30 cycles. Agarose gel electrophoresis was used for purification of PCR amplification products and plasmid digests. Subsequently, SpinX tubes (Corning) or a QIAexII kit (QIAGEN) was used for agarose gel extractions according to the manufacture's instructions. E. coli transformations were done as described previously (3). All cloned PCR products and transposon insertions were confirmed by nucleotide sequencing at the Columbia University DNA sequencing facility using an Applied Biosystem 3100 capillary sequencer.
flp-2 and tadV mutagenesis. Vectors for allelic exchange were constructed as follows. First, the segment including flp-1-flp-2-tadV-rcpC' was PCR amplified from genomic DNA extracted from CU1000N using the primers 5'-AACAACAATAGGAGCATTAAGACA-3' (flpcompUP) and 5'-GGTCATTGTCGACTAGTGCAC-3' (AaOCL1). This 1,344-bp PCR fragment, which includes 21 bp upstream of flp-1 through 269 bp into rcpC, was cloned into pCR2.1 TOPO (Invitrogen) to generate pSK273. This plasmid was then digested with EcoRI and ligated into pMB78 to generate pBP098, which contains the A. actinomycetemcomitans uptake signal sequence for transformation (39) (Bhattacharjee and Figurski, unpublished data).
The plasmid pBP098 was mutagenized using an EZ::TN <KAN-2> insertion kit (Epicenter), which randomly inserts a 1,221-bp Tn5-based Kmr transposon into the plasmid. Insertions in flp-2 and tadV were screened by PCR and confirmed by nucleotide sequencing. Plasmids containing insertions, in which the transposon's Kmr gene was transcribed in the same direction as the flp-rcp-tad genes, were selected for further studies. A. actinomycetemcomitans strain DF2200N was transformed with linearized pBP108, pBP109, and pBP110 (Table 1) and selected for Kmr transformants. The transformation protocol was provided by M. Bhattacharjee and D. H. Figurski (unpublished data). Transformations resulted in strains that have chromosomal insertions in flp-2 and tadV (designated Aa3237, Aa3072, and Aa3074) (Table 1). To confirm the mutations, genomic DNA was purified from the transformants using the DNAeasy genomic prep kits (QIAGEN) and screened by PCR using the following primers: 5'-TTTTTCAGTACTATAATGCCAC-3' (flp-pro-UP3), RP-1 (provided with the EZ::TN <KAN-2> insertion kit; Epicenter), 5'-GGGCTATCTACTGCTATATTTTG-3' (Flp2up), 5'-CATTAATAACCCAGTTCATTTTTTATC-3' (Flp2dwn), 5'-CTATAGTTAGCAAAAGTAGCTAAAAAATGATAAAAAATG-3' (AaUOBR1), and 5'-CTGCTCATCAAGACAATATTAG-3' (AaUOCL1).
Genetic complementation of the tadV mutation. The tadV gene was amplified from genomic DNA extracted from CU1000N by PCR using the AaUOBR1 and AaUOCL1 primers (see above) and cloned into pCR2.1 TOPO to generate pSK288. This plasmid was digested with BamHI and XhoI, and the tadV fragment was ligated into pJAK17 (J. A. Kornacki, unpublished results) (39), a derivative of pMMB67. The ligated plasmid with insert, pBP114, was mobilized by conjugation into the tadV mutant strains, Aa3072 and Aa3074.
Construction of flp-2-T7 expression vectors. The flp-2-T7 and flp-2-T7SD (where SD indicates that the construct carries the flp-1 Shine-Dalgarno sequence) open reading frame (ORFs) were PCR amplified from CU1000N genomic DNA using the primer pair 5'-GGGCTATCTACTACTGCTATATTTTG-3' (Flp2-up) and 5'-TTAACCCATTTGCTGTCCACCAGTCATGCTAGCCATGCTACTTTTGCTAACTATAGCGCC-3' (Flp2-T7-down) and the pair 5'-AACAACAATAGGAGCATTAAGACAATGATGGATTTACTGGATTACTTTTAC-3' (Flp1 + Flp2-up) and Flp2-T7-down, respectively. The primer Flp2-T7-down added a DNA coding sequence for the T7 epitope tag to the 3' end of the flp-2 gene. The PCR fragments were cloned into pCR2.1 TOPO (Invitrogen) to generate pBP024 (flp-2-T7) and pBP022 (flp-2SD-T7). The plasmids were digested with EcoRI, and the flp-2-T7 and flp-2SD-T7 fragments were ligated into pJAK16 (J. A. Kornacki, unpublished results) to generate pBP027 and pBP026, respectively. Plasmids pBP27 and pBP026 were transformed into E. coli Top10 resulting in strains BP039 and BP038.
flp-2 expression and detection. Expression experiments and detection of Flp2-T7, Flp2SD-T7, and Flp1-T7 proteins were done as described previously (20) with some modifications. All E. coli strains harboring expression vectors were grown overnight in 5 ml of LB broth supplemented with CHL. These overnight cultures were diluted 1:100 into fresh LB broth supplemented with CHL and grown for 3 h. Cultures were supplemented with 1 mM IPTG (isopropyl-ß-D-thiogalactopyranoside) to induce flp-2-T7, flp-2SD-T7, and flp-1-T7 expression. Bacterial cells were harvested and lysed by brief sonication. The cell pellet was resuspended and boiled for 5 min in Laemmli buffer. The volumes of bacterial cultures harvested were determined by taking absorbance readings of the optical density at 600 nm (OD600). Equivalent amounts of total protein were loaded on gels for immunoblot analysis.
Immunoblot analysis.
Protein samples were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analyzed by hybridizing with an
-T7 epitope-tagged antibody (dilution of 1:10,000; Novagen). An
-rabbit immunoglobulin G antibody (Sigma), conjugated to horseradish peroxidase (HRP), was used as a secondary antibody at a dilution of 1:50,000. Femto Western chemiluminescence reagent (Pierce) was used as a substrate for HRP.
Mutagenesis of rcpB. The rcpA'-rcpB-tadZ' DNA coding region was PCR amplified from genomic DNA extracted from CU1000N using the primers 5'-ATGGTAAGGTTCTGGCCGAAC-3' (AaRAR2) and 5'-CGCCCTTACAACTTAATACAGC-3' (AaXL1). The 1,556-bp PCR fragment includes the last 607 bp of rcpA through 453 bp into tadZ. This PCR generated fragment was cloned into pCR2.1 TOPO to generate pBP113, which was then digested with KpnI and XbaI. The resulting DNA fragment was ligated into pMB78 (digested with KpnI and SpeI) to generate pBP120. The plasmid pBP120 was mutagenized using an EZ::TN <KAN-2> insertion kit. As described above, insertions in the correct orientation were selected for further studies.
Adherent strain DF2200N and the isogenic, nonadherent strain Aa3138 were transformed (as previously described) with linearized and mutagenized pBP164, pBP133, pBP135, pBP165, pBP123, pBP166, pBP134, and pBP167, and we selected for Kmr transformants. To confirm the mutations, purified genomic DNA was screened by PCR using the following primers: 5'-CCCATCACGACCTAAGTTAA-3' (AaTadXL2), FP-1 (provided with the EZ::TN <KAN-2> insertion kit, Epicenter), 5'-TTCTTAAAAAATAGTGGGTTCATACAATG-3' (RcpBup), and 5'-GATCTAGTAATAACATAAAAAATACCTTC-3' (RcpBdwn).
Cloning of rcpB. The rcpB gene was PCR amplified from genomic DNA extracted from CU1000N using the following primers: 5'-AGATTCTTCCATACGACTCC-3' (AaRAR3) and 5'-GTCGACTTAATACTTCAATTGAACACGCTGATT-3' (RcpBSalIdwn). The primer RcpBSalIdwn added an SalI restriction site at the 3' end of the rcpB gene. The rcpB PCR-generated fragment was cloned into pCR2.1 to generate pBP131, which was digested with BamHI and SalI. The rcpB-containing fragment was ligated into pJAK12 (J. A. Kornacki, unpublished results). This ligated plasmid, pBP152, and pJAK12 were mobilized by conjugation into A. actinomycetemcomitans strain DF2200N to generate Aa3119 and Aa3118, respectively.
Mutagenesis of rcpB with wild-type rcpB expressed in trans. A. actinomycetemcomitans strains Aa3119 and Aa3118 were transformed as described above with linearized pBP164, pBP133, pBP135, pBP165, and pBP166 and selected for Kmr transformants. To allow the loss of plasmid pBP152 in the transformants, we inoculated each transformant in AAGM without selection, and the transformants were allowed to grow overnight. The transformants were then streaked onto AAGM plates without selection and passaged once or twice on AAGM plates. Ten individual colonies from each transformation strain were spotted on AAGM plates that contained CHL, SPT, KAN, or no antibiotic.
Transmission electron microscopy (TEM). A. actinomycetemcomitans strains were grown on AAGM plates without antibiotics or with appropriate antibiotics for 3 days at 37°C in 10% CO2, and cells were examined for pili, as described previously (18, 20).
Crystal violet adherence assays. To assay adherence, we used a previously described 96-well polystyrene crystal violet assay with some modifications (21, 25). A. actinomycetemcomitans strains were inoculated into 5 to 10 ml of AAGM broth. These cultures were allowed to grow for 24 h at 37°C. If necessary, the cultures were scraped to remove adherent bacteria. These bacterial suspensions (20 µl) were added to 96-well polystyrene plates that contained 100 µl of fresh AAGM and allowed to grow for 16 h. The medium was removed, and the cells were washed 15 times with double-distilled H2O to remove loosely adherent or nonadherent cells. The cells were stained with 25 µl of 1% crystal violet for 15 min. The wells were washed another 15 times with double-distilled H2O to remove excess crystal violet, and 200 µl of dimethyl sulfoxide was added to each well. The wells were incubated with dimethyl sulfoxide for 1.5 h to solubilize the crystal violet. The amount of released crystal violet was measured at the optical density at 590 nm in a plate reader (Molecular Devices SpectraMAX 340pc). Samples were tested in triplicate wells, and error bars indicate standard error.
Assay for autoaggregation. To assay for autoaggregation, A. actinomycetemcomitans strains were physically scraped with sterile wooden sticks to remove adherent bacteria from the walls of the culture tube and vortexed vigorously for several seconds. Autoaggregation was inspected visually for the presence of clumping and by light microscopy using phase-contrast optics.
Database sequence collection and phylogenetic analysis.
We used the application ORFCurator (31) to search all available
-proteobacteria with the full set of genes from the WCI in A. actinomycetemcomitans HK1651 and C. crescentus. We accepted all loci with two or more ORFs with BLAST hits (e-value less than 0.01) to any WCI gene. A maximum spacing of 5,000 base pairs between ORFs was allowed. We extracted flp gene sequences from these loci and examined each for the existence of the Flp pilin motif (GXXXXEY). We then excluded any flp genes that were not closely linked to those tadA sequences belonging to the
-proteobacterial clade arising from the horizontal transfer event from the
-proteobacteria (28). This led to the exclusion of all pseudomonad flp sequences and to several flp sequences from members of the Vibrionaceae [Vibrio vulnificus YJ016 (VV2665:NP_935458; VV2664:NP_935457) and Vibrio parahaemolyticus (VP2423:NP_798802)]. No tadA gene was linked to the flp-like ORF extracted from the Shigella flexneri 2a genome, but this gene was included in our analysis based on its similarity to other flp sequences from Enterobacteriaceae and the close relationship of the closely linked tadV-like ORF to other tadV ORFs from this group; flp sequences from close relatives of the
-proteobacterial clade (as determined by a tadA phylogenetic analysis) from Burkholderia pseudomallei and Magnetospirillum magnetotacticum were included as outgroups. All included sequences with their database sources and accession numbers, if available, are shown in Table 2.
|
Nucleotide sequence accession numbers. The DNA sequences of flp-2, tadV, and rcpB from A. actinomycetemcomitans strains DF2200N and IDH781N have been deposited in the GenBank database under the following accession numbers: DQ650320, DQ650321, DQ650322, DQ650323, DQ650324, and DQ650325.
| RESULTS |
|---|
|
|
|---|
Phenotypic analysis of tadV and flp-2 mutants. Like other previously examined mutants in the tad gene locus, all tadV mutants (e.g., Aa3074 and Aa3072) have smooth colony morphology and grow planktonically in broth (Fig. 2A and D). The ability of tadV mutants to form biofilms was severely reduced, as measured by a crystal violet biofilm assay (see Fig. 4), and individual bacteria do not clump, as observed under a light microscope (Fig. 2B and E). TEM confirmed that no fibrils are produced by these strains (Fig. 2C and F).
|
|
|
flp-2 expression. Examination of the upstream region of flp-2 revealed the lack of an obvious Shine-Dalgarno sequence, suggesting that the gene may be expressed poorly or not expressed (Fig. 5A). In contrast, there is a strong Shine-Dalgarno sequence 10 bp upstream of the flp-1 start codon (Fig. 5A). To test whether or not the flp-2 gene product can be detected, we cloned flp-2 with a C-terminal T7 epitope tag into a broad-host IPTG-inducible vector. We induced expression of Flp2-T7 and analyzed cell lysates by Western blotting with anti-T7-tag antibodies. We were unable to detect expression of Flp2-T7 in either E. coli or A. actinomycetemcomitans (Fig. 5B). To test if the lack of or lower expression of Flp2 was due to the absence of a Shine-Dalgarno sequence, we fused the sequence upstream of flp-1 to the flp-2-T7 coding sequence, and induced expression of the resulting construct, designated Flp2SD-T7 from the tacp promoter using IPTG. We were able to detect Flp2SD-T7 protein expression in E. coli within 1 h after the addition of IPTG (Fig. 5C), but expression was not detectable after 2 h postinduction, suggesting that the protein is unstable in this host. We were unable to detect expression of Flp2SD-T7 in A. actinomycetemcomitans (data not shown), indicating that the Flp2 protein is unstable and does not behave similarly to Flp1 (20).
|
-proteobacterial genomes. The phylogeny (Fig. 6A) confirmed an earlier analysis, which suggested that, with the exception of flp alleles found in H. ducreyi, all flp gene alleles in the second position in the gene cluster (i.e., flp-2) formed a monophyletic group, and all flp alleles in the first position in the gene cluster (i.e., flp-1) are also monophyletic. These results indicate that all flp-1 alleles are related to all flp-2 alleles by a single duplication event; i.e., every flp-1 is a paralog of every other flp-2, and vice versa. Our findings also suggested that flp-2 has been conserved and maintained as an independent ORF over a long period of time.
|
We used a likelihood-based technique (SLAC) (29, 30) that uses inferences of nucleotide change reconstructed on a given phylogeny using a model of sequence evolution to calculate dN and dS. This test can also assign a P value to the measured ratio to gauge the possibility that the result may have been observed by chance alone. Using the phylogeny as a guide, we tested the following five sequence groupings for evidence of selection: flp-1 from all Pasteurellaceae, flp-1 from A. actinomycetemcomitans strains alone, flp-2 from all Pasteurellaceae, flp-2 from A. actinomycetemcomitans strains alone, and flp-2 from all Pasteurellaceae but with only one A. actinomycetemcomitans strain (HK1651).
For flp-1, each test showed statistically significant evidence for both positive and negative selection both across all Pasteurellaceae and within A. actinomycetemcomitans (Fig. 6B). The negatively selected residues are concentrated in the hydrophobic domain of flp-1. There is more evidence of positive selection in the variable C terminus (Fig. 6B).
Across all Pasteurellaceae, flp-2 also showed evidence for negative (conservative) selection (Fig. 6C), which is consistent with the maintenance of the flp-2 duplicate over a long period of time. However, there was no statistically significant evidence that flp-2 is positively or negatively selected in strains of A. actinomycetemcomitans, suggesting that in these strains flp-2 may be evolving neutrally and may not have a function that is strongly acted on by selection.
rcpB mutagenesis and phenotypic characterization. To determine if rcpB is required for biofilm formation, we transformed A. actinomycetemcomitans strain DF2200N with eight different plasmids containing insertions throughout the length of the rcpB gene (Fig. 1 and Table 1). The presence of mutant rcpB alleles in the chromosome was determined by PCR amplification using a primer designed to the 3' end of the transposon and a second primer that anneals at the 3' end of the coding region of tadZ, a sequence not present on the transformation plasmids. These results were confirmed by observing a 1,221-bp shift in the size of the amplified rcpB gene, corresponding to the size of the transposon (data not shown).
We frequently obtained recombinants with mutant plasmids harboring insertions at the 3' end or in the last third of the rcpB gene (pBP135, pBP165, pBP123, pBP166, pBP134, and pBP167). Mutant strains with chromosomal insertions in these locations (Aa3245, Aa3235, Aa3250, Aa3234, Aa3229, and Aa3232) have rough colony morphologies and are adherent (Fig. 7 and 8). We rarely obtained recombinants using plasmids in which the transposon insertions were located at the 5' end of rcpB (pBP164 and pBP133) (Table 3). These recombinants displayed smooth colony morphologies and were nonadherent (data not shown). However, we observed no restoration of any adherence-associated phenotypes in these mutants when rcpB was expressed from a plasmid containing a tacp IPTG-inducible promoter. These results suggested that these mutations either had polar effects on the expression of downstream genes or that each of the 5' end mutants had undergone an additional mutation event resulting in the loss of the adherent phenotype.
|
|
|
We also used the 5' and 3' end insertional rcpB mutant alleles to transform a DF2200N strain carrying a plasmid expressing a wild-type copy of rcpB (pBP152; Spr). We readily obtained transformants that were both Kmr and Spr for all rcpB mutant alleles. These results show that allelic exchange can occur with both 5' and 3' end insertional rcpB mutant alleles in A. actinomycetemcomitans strains that have rcpB in trans. (Table 3).
We then asked if we could promote the loss of rcpB (pBP152) in these recombinant DF2200N strains. Previous experiments have shown that in the absence of selection, nonessential IncQ-based plasmids are rapidly lost in A. actinomycetemcomitans (M. Bhattacharjee and Figurski, unpublished). After several passages on nonselective medium, recombinants transformed with rcpB mutants with 3' end insertions were Sps and Kmr or both Kms and Sps, indicating recombination in the chromosome or recombination in the rcpB plasmid pBP152, respectively (Table 3). The only mutants that appeared to require pBP152 (i.e., those that always retained Spr) were those with 5' end mutations. This result indicates that the loss of the wild-type rcpB gene in rcpB mutants with insertions at the 5' end may be lethal (Table 3).
Characterization of 3' end rcpB insertion mutants. To look for any defects in the 3' end of rcpB insertion mutants (e.g., Aa3245, Aa3235, Aa3250, Aa3234, Aa3229, and Aa3232), we assayed for biofilm formation, the presence of fibrils, and autoaggregation. In a crystal violet biofilm assay, the rcpB mutants did not appear defective for adherence, relative to the wild-type A. actinomycetemcomitans strain DF2000N (Fig. 8). We observed the presence of bundled fibrils in mutant cells by TEM (Fig. 7C, G, J, M, P, and S), and the abundance and quality of the fibrils are comparable to wild-type A. actinomycetemcomitans. We also observed no change in autoaggregation of cells (Fig. 7B, F, I, L, O, and R). However, careful examination of colony morphology yielded some reproducible differences between strains. Mutants that harbor insertions closer to the 3' end of rcpB (Aa3229 and Aa3232) display a rough star-like colony morphology, as observed in wild-type DF2200N (Fig. 7N and Q). Colony morphology appears to have less structure with smoother surfaces in mutants that harbor insertions that are closer to the 5' end of rcpB (e.g., Aa3245, Aa3235, Aa3250, and Aa3234) (Fig. 7A, E, H, and K). We observed the emergence of spontaneous smooth, nonadherent colonies when these "smoother" rcpB mutants (e.g., Aa3245, Aa3235, and Aa3250) were grown on solid medium. We did not observe the emergence of spontaneous-smooth colonies in the mutants with insertions at the very 3' end of rcpB (e.g., Aa3234, Aa3229, and Aa3232) (Fig. 7D).
| DISCUSSION |
|---|
|
|
|---|
To investigate if these genes are required for adherence in A. actinomycetemcomitans, we directed insertional mutations to flp-2, tadV, and rcpB in conjunction with genetic complementation analysis. Our studies tested for all known adherence-related phenotypes: biofilm formation, presence of fibrils, rough colony morphology, and autoaggregation. We determined that tadV is required for biofilm formation. In contrast, flp-2 is not required for any adherence-related phenotypes in A. actinomycetemcomitans and may not be expressed. Mutations in rcpB are lethal to wild-type, adherent A. actinomycetemcomitans.
Similarly to the previously described tad mutants (18-20, 28), tadV mutants are smooth and nonadherent, do not autoaggregate, and do not produce pili. Mutants of tadV were recently described by Wang and Chen as having smooth-colony morphology (40). However, the authors were unable to further characterize these mutants due to an apparent polar effect on the expression of downstream genes. To confirm that tadV is required for adherence and to ensure that our mutants are not polar, we genetically complemented our tadV mutant strains with the wild-type tadV gene in trans. We observed complete complementation of all adherence-related phenotypes. Therefore, tadV is required for biofilm formation in A. actinomycetemcomitans. Recent studies (M. Tomich and D. H. Figurski, submitted for publication) indicate that tadV is the prepillin peptidase required for processing of the Flp1 major pilin subunit (17, 20).
Unlike the phenotypes displayed by previously described tad mutant strains, flp-2 mutants are phenotypically indistinguishable from wild-type A. actinomycetemcomitans. The flp-2 gene is the second flp allele in the tad locus, and its gene product is very similar to Flp1 (17, 20). The loss of adherence in the flp-1 mutant suggested that flp-2 may be a minor pilin subunit that is not sufficient for the assembly of fibrils. Here we have demonstrated that targeted insertional mutations in flp-2 do not affect biofilm formation, autoaggregation, colony morphology, or pilus biogenesis in A. actinomycetemcomitans. Findings by Wang and Chen in the A. actinomycetemcomitans strain D7S suggested that flp-2 mutants are defective for autoaggregation (40); however, we could not detect any differences in autoaggregation between our flp-2 mutant and wild-type A. actinomycetemcomitans. Despite the very close evolutionary relationship between DF2200N and D7S (serotype a) and their flp-2 alleles (Fig. 6A), it is formally possible that these results are due to differences in the strains used in these studies. To confirm our results, we constructed an flp-2 mutation in another wild-type clinical isolate of A. actinomycetemcomitans, IDH781 (serotype d) and observed no change in autoaggregation or any of the adherence-related phenotypes. We speculate that the flp-2 mutation constructed in the Wang and Chen study may be at least partially polar on downstream genes in the locus, explaining the observed partial phenotype (40).
Our results demonstrate clearly that flp-2 is not required for adherence. However, the striking similarity between Flp2 and Flp1, the major pilin subunit (17, 20), suggests that flp-2 may encode a pilin. We hypothesized that flp-2 may be required for adherence under different environmental conditions or that Flp2 might function as a minor pilin. To address these questions, we performed a series of flp-2 expression experiments. We found that inducing expression of flp-2 in trans cannot suppress a flp-1 mutation in A. actinomycetemcomitans and that flp-2 is not expressed. We determined that flp-2 lacks a convincing Shine-Dalgarno sequence, though limited expression of Flp2 is detected from our flp-1 Shine-Dalgarno-flp-2 fusion. Our expression studies suggest that Flp2 does not accumulate in A. actinomycetemcomitans, which is consistent with the flp-2 mutant phenotypes.
Previous work on the flp gene phylogeny suggested that all flp-1 alleles were related to all flp-2 alleles by a single, ancient duplication event that occurred either before the emergence of the Pasteurellaceae lineage or early in the family's history. The two flp alleles suggested that there is, or was, a functional benefit in maintaining duplicate genes. The predicted protein products of both flp-1 and flp-2 have identical or similar residues at equivalent positions, suggesting conservative maintenance of key functional amino acids by natural selection.
From an evolutionary perspective, it could be argued that flp-2 has been conserved as a necessary part of the tad gene secretion system for production of Flp pili. However, our molecular studies strongly suggest that flp-2 has no function in A. actinomycetemcomitans. We offer two possible explanations to reconcile these results: flp-2 might be required for Flp pilus production in A. actinomycetemcomitans only under circumstances absent from our laboratory assays, or flp-2 might be required in other Pasteurellaceae family members but not in A. actinomycetemcomitans. Both possibilities can be addressed by examining the evolution of flp genes in the Pasteurellaceae family and in A. actinomycetemcomitans strains. For instance, natural selection acting on flp-2 in A. actinomycetemcomitans could signal that the gene product is required in circumstances not accounted for in our laboratory assays. We used a test that examines sequence data for evidence of a preponderance of nonneutral evolutionary changes signaled by codon changes that either change (nonsynonymous) or do not change (synonymous) the amino acid. If either change predominates, then natural selection may be acting at that sequence position. An advantage of this type of analysis is that both conservative (negative) selection and selection that favors change (positive) can be detected.
We examined flp-1 and flp-2 alleles for all available Pasteurellaceae family members and then restricted each analysis to available sequence from A. actinomycetemcomitans only. We found significant evidence for selection of flp-1 both in the Pasteurellaceae and when the analysis was limited to A. actinomycetemcomitans. This analysis also showed that the hydrophobic portion of the Flp1 molecule was negatively selected (i.e., selected not to change), while the C terminus was positively selected (i.e., selected to change). This is consistent with the idea that the hydrophobic amino terminal domain is buried in the center of the pilus, where it is constrained by the structural contacts it must make to form the pilus, while the carboxyl terminus might be exposed to the outside and subject to selective pressures in the host or environment.
The flp-2 clade in the Pasteurellaceae also showed evidence for negative selection, albeit less than flp-1. This suggested that the flp-2 gene is or was expressed and acted on by selection at some point in the history of Pasteurellaceae. However, when the analysis was restricted to include only flp-2 from A. actinomycetemcomitans strains, there was no statistically significant evidence of nonneutral selection. In contrast, when the analysis excluded A. actinomycetemcomitans flp-2 genes, evidence for selection was present, suggesting that flp-2 may be a functioning gene in other Pasteurellaceae species. This is consistent with our molecular data that show no apparent role for flp-2 in A. actinomycetemcomitans and suggests that the conservation of flp-2 may be simply vestigial in this species.
The pattern of selection of flp-2 and flp-1 may explain the seemingly paradoxical observation made in some strains of A. actinomycetemcomitans (40) that certain flp-2 ORFs are more similar to one another than their neighboring flp-1 genes are to each other. If flp-2 ORFs are evolving randomly without significant selection while portions of flp-1 genes (e.g., the C terminus) are being positively selected to change, then the active and functional flp-1 may have changed more over a given amount of time than the defunct flp-2. This result illustrates that similarity values are not always the best indicators of sequence conservation through natural selection.
It should be noted, however, that the test employed above can only detect selection at the amino acid level; if the active product of flp-2 is RNA, its selection would not be detected. It is also possible that flp-2 is only selected under extremely rare circumstances and/or that changes in flp-2 only create very subtle defects in fitness.
We also show that rcpB appears to be essential in adherent (tad+) A. actinomycetemcomitans. In this study, we readily obtained recombinants that harbor insertions at the 3' third of the rcpB gene. These transformants are rough and as adherent as wild-type A. actinomycetemcomitans. This finding suggests that the RcpB protein produced in these mutants is either still functional or not required. Based on the location of the insertions in these mutants, we speculate that the last 48 C terminal residues of RcpB, which comprise 167 amino acids (Fig. 1), may not be required for adherence in A. actinomycetemcomitans.
We only infrequently obtained recombinants using mutant plasmids that have transposon insertions at the 5' end of the rcpB gene. These recombinants are nonadherent and exhibit smooth-colony morphology, but we did not observe complementation of adherence or adherence-related phenotypes with wild-type rcpB gene provided in trans. These mutants may be polar or have additional mutations that result in the loss of adherence. Wang and Chen (40) described mutations of rcpB to be nonadherent and to have smooth-colony morphologies. They also noted that recombinants in rcpB were rare (40). However, the authors did not complement their rcpB mutations with wild-type rcpB in trans. The 5'-end mutant plasmids harbor insertions that are predicted to eliminate the function of rcpB. The low rate of transformation of these rcpB mutant alleles suggested that loss of rcpB is toxic to wild-type A. actinomycetemcomitans. We readily obtained recombinants when we transformed an isogenic, spontaneous-smooth, nonadherent derivative of DF2200N. We conclude that an intact, wild-type rcpB gene is essential in the context of a functional tad locus.
Although all the chromosomal rcpB mutants (all 3' end insertion mutations) constructed in this study appeared to be adherent, we did observe slight changes in colony morphology. Additionally, the emergence of spontaneous smooth and nonadherent colonies was only observed in strains that harbored insertions toward the 5' end of rcpB. These results indicate that mutants that harbor insertions closer to the 5' end of rcpB are unstable, and these mutations are slightly toxic to A. actinomycetemcomitans. It is possible that smooth, nonadherent variants may have acquired suppressor mutations to relieve the toxicity associated with insertional inactivation of rcpB.
The role of rcpB in biofilm formation by A. actinomycetemcomitans remains unknown. However, the requirement for the RcpB protein in the context of a functional Tad system raises interesting questions about the possible roles of rcpB in adherence. This situation is not unprecedented in the biology of secretion systems. For example, DotL/IcmO, a member the Icm/Dot type IVb system in Legionella pneumophila, has been demonstrated to be essential for viability (2). dotL/icmO mutations and lethality can be suppressed by mutations that inactivate the Icm/Dot secretion system (2). DotL/IcmO has no sequence similarity to RcpB, but it has been proposed to be involved the regulation of type IV secretion.
Because RcpB is located in the outer membrane (12), it is tempting to speculate that the function of RcpB is linked to the RcpA secretin protein. The function of RcpB could be similar to that of protein S (PulS/OutS) of Klebsiella oxytoca and Erwinia chrysanthemi, which is a secretin-stabilizing protein found in the Pul and Out type II secretion systems (32). Although RcpB does not exhibit similarity to protein S, it is possible that RcpB represents a new, unrelated class of secretin-stabilizing proteins.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the National Institutes of Health to D. H. Figurski (5R01DE014713-04). B.A.P. is supported by the NIH Kirschstein-NRSA Individual Fellowship Program.
| FOOTNOTES |
|---|
Supplemental material for this article may be found at http://jb.asm.org/. ![]()
Present address: Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY 10032. ![]()
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles: